Harmony Biosciences Holdings (HRMY) Change in Account Payables (2019 - 2025)
Harmony Biosciences Holdings (HRMY) has disclosed Change in Account Payables for 7 consecutive years, with -$8.6 million as the latest value for Q4 2025.
- Quarterly Change in Account Payables fell 369.24% to -$8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.9 million through Dec 2025, up 173.35% year-over-year, with the annual reading at $3.9 million for FY2025, 173.35% up from the prior year.
- Change in Account Payables hit -$8.6 million in Q4 2025 for Harmony Biosciences Holdings, down from -$2.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $10.8 million in Q2 2025 to a low of -$12.2 million in Q3 2024.
- Historically, Change in Account Payables has averaged $437200.0 across 5 years, with a median of $992000.0 in 2021.
- Biggest YoY gain for Change in Account Payables was 4021.48% in 2024; the steepest drop was 50529.17% in 2024.
- Year by year, Change in Account Payables stood at -$3.2 million in 2021, then tumbled by 97.07% to -$6.3 million in 2022, then soared by 198.93% to $6.2 million in 2023, then plummeted by 48.16% to $3.2 million in 2024, then tumbled by 369.24% to -$8.6 million in 2025.
- Business Quant data shows Change in Account Payables for HRMY at -$8.6 million in Q4 2025, -$2.0 million in Q3 2025, and $10.8 million in Q2 2025.